If a thyroid nodule has just been flagged on your ultrasound report, the first thing you're feeling is probably fear — the word "nodule" sitting a little too close to the word "tumour" in your mind. So let's start where the evidence starts: thyroid nodules are one of the most common findings in all of medicine, and the large majority — around 90 to 95% — are completely benign. Many people walk around with one or more and never know. The purpose of everything that follows is not to confirm something frightening; it's to sort the small number of nodules that need attention from the very large number that don't.
This article walks you through exactly what happens next in Canada: how radiologists grade your nodule with a TI-RADS score, when a fine-needle aspiration (FNA) biopsy is recommended, what your TSH blood test is checking for, the referral pathway from GP to endocrinologist or surgeon, and — importantly — the reassuring reality of what turns out to be cancer versus benign.
What a TI-RADS score actually means
When the radiologist looked at your thyroid ultrasound, they didn't just note "there's a nodule." They graded it using a standardised system called ACR TI-RADS — the American College of Radiology's Thyroid Imaging Reporting and Data System. It exists precisely so that a nodule isn't judged on gut feeling, but on a consistent, points-based checklist.
The radiologist assigns points across five ultrasound features of the nodule:
- Composition — is it fluid-filled (cystic), solid, or a mix? Purely cystic and spongiform nodules score lowest, because fluid is reassuring.
- Echogenicity — how bright or dark it appears compared with surrounding thyroid tissue. Very dark (hypoechoic) nodules score higher.
- Shape — is it wider than it is tall, or taller than wide? A "taller-than-wide" shape scores higher.
- Margin — are the edges smooth, or irregular/ill-defined? Ragged or extending margins score higher.
- Echogenic foci — tiny bright spots. Certain kinds (punctate microcalcifications) score higher; large "comet-tail" spots are reassuring.
The points add up to a single grade from TR1 (benign) to TR5 (highly suspicious):
| TI-RADS level | What it means | Biopsy (FNA) generally considered when… |
|---|---|---|
| TR1 | Benign | No biopsy |
| TR2 | Not suspicious | No biopsy |
| TR3 | Mildly suspicious | ≥ 2.5 cm (monitor from 1.5 cm) |
| TR4 | Moderately suspicious | ≥ 1.5 cm (monitor from 1 cm) |
| TR5 | Highly suspicious | ≥ 1 cm (monitor from 0.5 cm) |
The key insight: the recommendation to biopsy depends on the TI-RADS grade and the size together. A higher grade triggers a biopsy at a smaller size. A small TR3 nodule may simply be watched; a larger TR5 nodule warrants a closer look. Your radiology report usually states the recommendation in plain terms — often something like "FNA recommended" or "recommend follow-up ultrasound in 12 months." If you're not sure which category yours falls into, that's the first thing to ask about.
Fine-needle aspiration (FNA) biopsy — the key test
If your nodule's TI-RADS grade and size cross the threshold, the next step is a fine-needle aspiration (FNA) biopsy. This is the single most informative test for telling a benign nodule from a suspicious one. It sounds daunting, but it's a quick outpatient procedure: guided by ultrasound, a doctor passes a very thin needle into the nodule and draws off a small sample of cells for a pathologist to examine. It's usually done without sedation and most people describe it as comparable to a blood draw.
The pathologist reports the result using a standardised framework called the Bethesda System, which sorts the sample into one of six categories:
| Bethesda category | Meaning |
|---|---|
| I | Non-diagnostic — not enough cells; may need repeating |
| II | Benign — the most common result, very reassuring |
| III | Atypia of undetermined significance — indeterminate |
| IV | Follicular neoplasm — indeterminate, often needs more work-up |
| V | Suspicious for malignancy |
| VI | Malignant |
The large majority of biopsies come back Bethesda II — benign. It's worth knowing that FNA biopsy wait times in Canada vary: depending on how urgent the finding looks and the capacity of your local centre, it can be anywhere from a couple of weeks to a few months. Genuinely suspicious nodules are prioritised. If your report reads as low-risk, a longer wait is not a sign anyone is worried — it's a sign they aren't.
The bloodwork: what TSH tells you
Alongside the imaging, your GP will almost always order a TSH (thyroid-stimulating hormone) blood test. This checks how the nodule is behaving hormonally rather than how it looks.
If your TSH comes back low, it can mean the nodule is producing thyroid hormone on its own — a so-called "hot" or autonomous nodule. Here's the reassuring part: hot nodules are almost always benign. A low TSH typically prompts a nuclear medicine thyroid scan rather than a biopsy, because an overactive nodule is far more likely to be a hormone problem than a cancer one. If your TSH is normal or high, the assessment focuses on the ultrasound and, if indicated, the FNA.
If you want to understand what your specific TSH number means and how it fits the wider thyroid picture, our companion guide on what a TSH result actually means in Canada breaks it down clearly.
The pathway: from ultrasound to a plan
It helps to see where you are in the sequence, because it clarifies what's next:
- GP visit → a symptom, a lump you or your doctor felt, or an unrelated scan led to a thyroid ultrasound.
- Thyroid ultrasound (done) → the nodule is found and given a TI-RADS grade.
- TSH bloodwork → ordered to check the nodule's hormonal activity.
- Endocrinologist assessment / FNA biopsy → if the grade and size warrant it, you're referred to an endocrinologist who assesses the nodule and, where indicated, arranges the FNA. In some centres the biopsy is arranged directly through radiology.
- Thyroid surgeon → only if surgery is genuinely being contemplated — for example a biopsy that's suspicious or malignant, a very large nodule causing symptoms, or one pressing on the windpipe or swallowing.
But by far the most common destination on this map is the quietest one: most nodules are simply monitored with a repeat ultrasound in 6 to 24 months to confirm they're stable. No biopsy, no surgery — just watchful, evidence-based follow-up.
Before you leave your next appointment, make sure you know your nodule's TI-RADS score, its size in centimetres, and your TSH result. Those three data points determine everything that follows — whether an FNA is indicated, whether you're referred to endocrinology, and whether you're on a monitoring or an active pathway. Ask for them directly.
What's actually cancer — and what's benign
This is the part worth reading twice, because it's where the reassurance is grounded in numbers rather than hope. Around 90% or more of thyroid nodules are benign. The odds are firmly on your side before a single further test is done.
And even in the minority where a nodule does turn out to be cancer, the picture is far gentler than most people fear. The most common thyroid cancer by a wide margin is papillary thyroid cancer, which is typically slow-growing and highly treatable, with an excellent long-term prognosis — survival rates for localised disease are among the highest of any cancer. Thyroid cancer is one of the areas of oncology where "found early and treated" overwhelmingly means "lived a full, normal life." So the goal of the TI-RADS grading, the TSH, and — if needed — the FNA is not to brace you for bad news. It's to give you certainty, which in the overwhelming majority of cases is reassuring certainty.
A note for South Asian and NRI patients
Thyroid disease is notably common in South Asian populations — both hypothyroidism and autoimmune thyroid conditions like Hashimoto's, and correspondingly nodules are frequently found. If you're a South Asian or NRI patient in Canada who has just had a nodule flagged, it's a common finding in your community, not an unusual one, and the same reassuring statistics apply. It's simply a reason to make sure your TI-RADS score, size, and TSH are properly reviewed and followed up — rather than a reason for extra alarm.
Most nodules are not urgent — but a few features are. If you develop a rapidly enlarging neck mass, difficulty breathing or swallowing, or a hard, fixed nodule together with a hoarse voice, don't wait for a routine appointment — seek prompt medical review. These are uncommon, but they warrant faster attention.
What to ask your GP
Walk into your next appointment with these questions, and you'll leave knowing exactly where you stand:
- What is my nodule's TI-RADS score, and how large is it (in cm)? — this pairing decides whether a biopsy is indicated.
- What was my TSH? — and if it's low, do I need a thyroid uptake scan for a possible hot nodule?
- Is an FNA biopsy recommended for me, or am I on a monitoring pathway?
- Should I be referred to an endocrinologist? — and if so, is the referral flagged routine or urgent?
- When is my repeat ultrasound, if I'm being monitored?
If you're waiting to be seen and want these questions answered now, an endocrinologist wait in Canada can run into months — our guide on endocrinologist wait times explains why, and what you can do in the meantime.
How a specialist opinion from Ginie Health helps
Here's the service in plain terms for your exact situation — a nodule found, questions swirling, and possibly a long wait ahead. You upload your ultrasound report (with its TI-RADS score), your TSH result, and your FNA/Bethesda result if you already have one. Within 6 hours, for $45 CAD, you receive a written clinical opinion from an endocrinologist trained at PGIMER Chandigarh or AIIMS — among the finest medical institutions in the subcontinent.
The opinion explains, in language you can actually follow, what your TI-RADS score and nodule size mean, whether an FNA biopsy is genuinely indicated, what your TSH is telling you, and exactly what to raise with your GP or at your Canadian endocrinology appointment. It doesn't replace your in-person care — it makes the waiting time count and helps you walk in informed. If you'd rather talk it through, a live video consultation is available for $75 CAD. No referral required for either.